Education
About Us
Working with TipRanks
Follow Us
Medicinova (MNOV)
NASDAQ:MNOV
Total Valuation
Medicinova has a market cap or net worth of $67.68M. The enterprise value is .
Market Cap$67.68M
Enterprise Value
Share Statistics
Medicinova has 49.05M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49.05M
Owned by Insiders2.88%
Owned by Instutions2.61%
Financial Efficiency
Medicinova’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -15.67%.
Return on Equity (ROE)-13.74%
Return on Assets (ROA)-12.93%
Return on Invested Capital (ROIC)-15.67%
Return on Capital Employed (ROCE)-15.72%
Revenue Per Employee$0
Profits Per Employee-$220,028,951.538
Employee Count13
Asset Turnover0.02
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medicinova is -8.58. Medicinova’s PEG ratio is 0.21.
PE Ratio-8.58
PS Ratio73.57
PB Ratio1.18
Price to Fair Value1.18
Price to FCF-9.87
Price to Operating Cash Flow-9.90
PEG Ratio0.21
Income Statement
In the last 12 months, Medicinova had revenue of $0.00 and earned -$2.86B in profits. Earnings per share was -$0.17.
Revenue$0.00
Gross Profit-$10.72K
Operating Income-$12.68M
Pretax Income-$11.04M
Net Income-$2.86B
EBITDA-12.65M
Earnings Per Share (EPS)-0.17
Cash Flow
In the last 12 months, operating cash flow was -$10.64M and capital expenditures -$895.00, giving a free cash flow of -$10.64M billion.
Operating Cash Flow-$10.64M
Free Cash Flow-$10.64M
Free Cash Flow per Share-$0.22
Dividends & Yields
Medicinova pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-10.13%
Earnings Yield-11.65%
Stock Price Statistics
Beta0.13
52-Week Price Change-10.39%
50-Day Moving Average1.61
200-Day Moving Average1.71
Relative Strength Index (RSI)36.40
Average Volume (3m)14.94K
Important Dates
Medicinova upcoming earnings date is Apr 26, 2023, TBA.
Last Earnings DateJul 27, 2022
Next Earnings DateApr 26, 2023
Ex-Dividend Date―
Financial Position
Medicinova as a current ratio of 15.61, with Debt / Equity ratio of <0.01
Current Ratio15.61
Quick Ratio15.61
Debt to Market Cap0.00
Net Debt to EBITDA5.14
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medicinova has paid -$32.92K in taxes.
Income Tax-$32.92K
Effective Tax Rate-0.04%
Enterprise Valuation
Medicinova EV to EBITDA ratio is -2.31, with an EV/FCF ratio of -3.06.
EV to Sales22.79
EV to EBITDA-2.31
EV to Free Cash Flow-3.06
EV to Operating Cash Flow-3.07
Balance Sheet
Medicinova has $40.36M in cash and marketable securities with $193.77K in debt, giving a net cash position of -$40.17M billion.
Cash & Marketable Securities$40.36M
Total Debt$193.77K
Net Cash-$40.17M
Net Cash Per Share-$0.82
Tangible Book Value Per Share$0.98
Margins
Gross margin is 100.00%, with operating margin of -990.03%, and net profit margin of -857.15%.
Gross Margin100.00%
Operating Margin-990.03%
Pretax Margin-856.85%
Net Profit Margin-857.15%
EBITDA Margin-988.00%
EBIT Margin-990.03%
Analyst Forecast
The average price target for Medicinova is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.00
Price Target Upside552.17%
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast